InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Jonathan McNeill, Chief Business Officer, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 26 open-market SEC Form 4 transactions: 0 purchases worth $0 and 26 sales worth $4.6M, reported from Sep 20, 21 to Jun 22, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 26 | CBIOCRESCENT BIOPHARMA, INC. | SELL | 20.5K | $17.99 | $370K |
| Aug 19, 24 | DYNDyne Therapeutics, Inc. | SELL | 2.4K | $46.00 | $108K |
| Jun 11, 24 | DYNDyne Therapeutics, Inc. | SELL | 1.8K | $31.34 | $57K |
| May 16, 24 | DYNDyne Therapeutics, Inc. | SELL | 2.3K | $28.59 | $64K |
| Mar 11, 24 | DYNDyne Therapeutics, Inc. | SELL | 17.8K | $25.71 | $454K |
| Mar 8, 24 | DYNDyne Therapeutics, Inc. | SELL | 54.6K | $27.31 | $1.5M |
| Mar 7, 24 | DYNDyne Therapeutics, Inc. | SELL | 2.4K | $25.85 | $63K |
| Mar 1, 24 | DYNDyne Therapeutics, Inc. | SELL | 14.1K | $29.70 | $398K |
| Feb 29, 24 | DYNDyne Therapeutics, Inc. | SELL | 4.3K | $27.50 | $117K |
| Jan 26, 24 | DYNDyne Therapeutics, Inc. | SELL | 19.8K | $25.14 | $486K |
| Jan 4, 24 | DYNDyne Therapeutics, Inc. | SELL | 2.0K | $18.04 | $36K |
| Jan 3, 24 | DYNDyne Therapeutics, Inc. | SELL | 10.3K | $19.03 | $196K |
| Jan 2, 24 | DYNDyne Therapeutics, Inc. | SELL | 11.9K | $13.10 | $156K |
| Dec 11, 23 | DYNDyne Therapeutics, Inc. | SELL | 1.2K | $10.72 | $13K |
| Sep 18, 23 | DYNDyne Therapeutics, Inc. | SELL | 1.3K | $9.41 | $12K |
| Sep 12, 23 | DYNDyne Therapeutics, Inc. | SELL | 1.3K | $10.41 | $13K |
| Jun 13, 23 | DYNDyne Therapeutics, Inc. | SELL | 1.3K | $12.43 | $16K |
| Jun 12, 23 | DYNDyne Therapeutics, Inc. | SELL | 1.0K | $13.00 | $13K |
| Mar 14, 23 | DYNDyne Therapeutics, Inc. | SELL | 1.2K | $13.33 | $16K |
| Mar 13, 23 | DYNDyne Therapeutics, Inc. | SELL | 1.0K | $13.00 | $13K |
| Jan 18, 23 | DYNDyne Therapeutics, Inc. | SELL | 10.0K | $14.03 | $140K |
| Jan 9, 23 | DYNDyne Therapeutics, Inc. | SELL | 30.1K | $11.57 | $349K |
| Dec 12, 22 | DYNDyne Therapeutics, Inc. | SELL | 472 | $10.87 | $5K |
| Mar 11, 22 | DYNDyne Therapeutics, Inc. | SELL | 481 | $8.73 | $4K |
| Sep 21, 21 | DYNDyne Therapeutics, Inc. | SELL | 729 | $16.11 | $12K |
| Sep 20, 21 | DYNDyne Therapeutics, Inc. | SELL | 545 | $15.61 | $9K |